Patent infringement: Moderna, Pfizer sued by Promosome over mRNA technology in COVID vaccines Ruchika Sharma8 Jun 2023 1:30 PM ISTPromosome accused the companies of copying technology that allows for doses of mRNA that are small enough to use safely and effectively in the...
Novavax exec says its new COVID shot should work against variants on rise Ruchika Sharma6 Jun 2023 2:30 PM ISTGaithersburg: Novavax Inc's head of research and development has said an updated COVID-19 vaccine the company is already producing is likely to...
Antibiotics combo promising against multidrug-resistant bacterial infections: Result from two phase 3 trials Medha Baranwal6 Jun 2023 10:45 AM ISTUSA: Findings from two phase 3 trials have shown the investigational antibiotic combination aztreonam-avibactam (ATM-AVI) to be safe and effective for...
Pfizer announces positive results from phase 3 studies of novel antibiotic combination aztreonam-avibactam in treating serious bacterial infections Ruchika Sharma4 Jun 2023 2:00 PM ISTNew York: Pfizer Inc. has announced positive results from the Phase 3 program comprising the REVISIT and ASSEMBLE studies evaluating the efficacy,...
Pfizer bags USFDA nod for RSV vaccine Abrysvo for older adults Ruchika Sharma1 Jun 2023 12:00 PM ISTThe FDA's decision is based on the data from the pivotal Phase 3 clinical trial (NCT05035212) RENOIR (RSV vaccine Efficacy study iNOlder adults...
Pfizer India, Apollo Hospital launch Centre of Excellence for adult vaccination in Hyderabad MD Bureau28 May 2023 2:00 PM ISTThe centre will immunize against various vaccine-preventable diseases such as Pneumococcal disease, Hepatitis A and B, Human Papilloma Virus (HPV),...
Patent infringement: Alnylam Pharma files new lawsuits against Pfizer, Moderna over COVID vaccines Ruchika Sharma27 May 2023 3:18 PM ISTAlnylam is again seeking an unspecified share of royalties from the companies' vaccine sales.
USFDA nod to Pfizer Paxlovid for adult patients at high risk of progression to severe COVID 19 Ruchika Sharma26 May 2023 1:30 PM ISTPAXLOVID is a SARS-CoV-2 main protease (Mpro) inhibitor (also known as SARS-CoV-2 3CL protease inhibitor) therapy.
Aurobindo Pharma arm gets USFDA nod for Carboprost Tromethamine Injection Ruchika Sharma26 May 2023 11:30 AM ISTCarboprost Tromethamine injection is indicated for the treatment of postpartum hemorrhage due to uterine atony which has not responded to conventional...
CureVac files expanded patent lawsuit against Pfizer/BioNTech over mRNA technology Ruchika Sharma20 May 2023 3:29 PM ISTGermany: CureVac NV said on Friday it had filed an expanded patent infringement claim against Pfizer Inc and BioNTech over the use of mRNA...
USFDA panel votes in support of Pfizer RSV maternal vaccine Ruchika Sharma19 May 2023 3:57 PM ISTNew York: Pfizer Inc. has announced that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory...
Immediately suspend use of Magnex, Magnex Forte, Zosyn, Magnamycin: Pfizer warns doctors, chemists against use of 4 antibiotics Farhat Nasim19 May 2023 2:23 PM ISTNew Delhi: Citing an alert on "deviation in manufacturing process", drug major Pfizer has initiated temporary suspension of the sale and use of its...
